Quintiles Wins Society for Clinical Research Sites’ 2014 Eagle Award
October 14 2014 - 8:00AM
Business Wire
Recognized for leadership and professionalism
in site support two years in a row
Quintiles today announced that the company was awarded the
Society for Clinical Research Sites’ (SCRS) 2014 Clinical Research
Organization (CRO) Eagle Award. The award, which recognizes
outstanding leadership, professionalism, integrity, passion and
dedication, was presented during the annual SCRS Site Solutions
Summit.
"It is such an honor to be recognized again and receive this
award for the second year in a row,” said Lindy Jones, senior vice
president, Integrated Site Services, Quintiles. “Our ambition of
transforming clinical development and accelerating pipelines to
achieve better patient outcomes is only possible through the
dedication and hard work of our investigators and sites. I would
like to thank the investigators who voted for us. We will continue
to look at how we can better partner together.”
“We are delighted to present the Eagle Award to Quintiles,” said
SCRS President Christine Pierre. The award reflects the opinions of
almost 2,000 investigative sites across the globe. Quintiles’
integrity in consistently demonstrating their keen interest in
partnering with sites landed them with this prestigious
recognition.”
Prior to the Site Solutions Summit, SCRS members, which are
investigative sites, were invited to nominate the sponsor and CRO
they believe best demonstrates partnership commitment. The other
criteria include: availability of qualified staff to support the
sites, demonstration of collaboration, protocol design and
execution, financial consideration, and partnering with sites for
future work. The finalists were those sponsors and CROs that ranked
in the 75th percentile or greater of nominations received. Once the
finalists were identified, voting was open to all sites
globally.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s
largest provider of biopharmaceutical development and commercial
outsourcing services. With a network of more than 29,000
employees conducting business in approximately 100 countries, we
helped develop or commercialize all of 2013’s top-100 best-selling
drugs on the market. Quintiles applies the breadth and depth of our
service offerings along with extensive therapeutic, scientific and
analytics expertise to help our customers navigate an increasingly
complex healthcare environment as they seek to improve efficiency
and effectiveness in the delivery of better healthcare outcomes. To
learn more about Quintiles, please visit www.quintiles.com.
About SCRS
SCRS is a trade organization representing global clinical
research sites representing sites in 39 countries. SCRS’ mission is
to unify the voice of the global clinical research site community
for site sustainability. SCRS has become an active partner in
industry-wide dialogues focused on improving the clinical research
enterprise among the many industry initiatives. Sites, as well as
companies that sponsor or support the work conducted at the
clinical research sites, will benefit from membership. Visit
www.myscrs.org.
Click here to subscribe to Mobile Alerts for Quintiles.
QuintilesMari Mansfield, Media Relations
(mari.mansfield@quintiles.com)+ 1-919-998-2639 (office)
+1-919-259-3298 (mobile)orKarl Deonanan, Investor Relations
(InvestorRelations@quintiles.com)+1-919-998-2789
Qimonda AG Ads (NYSE:QI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Qimonda AG Ads (NYSE:QI)
Historical Stock Chart
From Jul 2023 to Jul 2024